Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diarylheptanoid compounds in curcuma zedoary and medicinal application thereof

A technology of diphenylheptane and compound, which is applied in the field of diphenylheptane compounds and achieves the effect of good research and development prospect and novel structure

Active Publication Date: 2014-04-23
SHENYANG PHARMA UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no relevant report on the anti-inflammatory effect of the 25 new diphenylheptane compounds involved in the present invention to inhibit the release of inflammatory mediators such as NO

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diarylheptanoid compounds in curcuma zedoary and medicinal application thereof
  • Diarylheptanoid compounds in curcuma zedoary and medicinal application thereof
  • Diarylheptanoid compounds in curcuma zedoary and medicinal application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1: Extraction and separation of new diphenylheptane compounds in Curcuma Curcumae in Guangxi

[0024]The medicinal material was purchased in Guilin City, Guangxi Province, and was identified as Curcuma kwangsiensis S.G.Lee et C.F.Ling by Professor Sun Qishi, School of Chinese Materia Medica, Shenyang Pharmaceutical University. Rhizome 10kg, adding 70% ethanol with 3 times of raw material weight by weight to volume ratio and heating and reflux extracting 3 times, each time for 3 hours, combining the extracts, reclaiming the solvent, obtaining the ethanol extract and being dispersed in water of 5 times by weight to volume ratio, respectively Extract 3 times with cyclohexane equal to the volume of water, then extract the extracted water phase 3 times with ethyl acetate equal to the volume of water, combine the ethyl acetate extracts, and recover the solvent to obtain the total ethyl acetate extract 65g (EE), the extracted aqueous phase was then extracted three time...

Embodiment 2

[0069] Example 2: Experiment of the inhibitory activity of compound 1-25 on the release of nitric oxide (NO) from mouse mononuclear macrophage RAW264.7 induced by lipopolysaccharide

[0070] Mouse mononuclear macrophage RAW264.7 (ATCC TIB-71) was cultured in 10% heat-inactivated (56oC, 30min) fetal bovine serum (FBS), 100U / mL penicillin sodium (Gibco), 100μg / mL streptavidin In the RPMI1640 (Gibco) culture medium of the prime (Gibco), 37oC, 5%CO Z grown in a constant temperature incubator. Because NO is extremely unstable, it is quickly metabolized into nitrous acid (NO) in the cell culture supernatant. 2 - ), so the Griess method was used to determine the NO in the sample 2 - concentration as an indicator of NO levels. Griess reagent A: 0.1% N-naphthalene diamine dihydrochloride (naphthylene diamine dihydrochloride) dissolved in water: Griess reagent B: 1% p-aminobenzenesulfonamide (sulphanilamide) dissolved in 5% H 3 PO 4 middle. Mix reagents A and B in equal volumes ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines and discloses new diarylheptanoid compounds extracted and separated from Guangxi curcuma zedoary and application thereof in the field of medicines. The chemical structure of the diarylheptanoid compounds is determined by spectrum technology such as a high resolution mass spectrum, one-dimensional and two-dimensional nuclear magnetic resonance spectrum and the like, and a chemical method. The diarylheptanoid compounds can be combined with a pharmaceutically acceptable carrier to prepare clinically acceptable medicines for anti-inflammatory treatment. Experiments for inhibiting lipopolysaccharide-induced rat macrophage from synthesizing nitric oxide (NO) in vitro prove that: the diarylheptanoid compounds have high activity of inhibiting the nitric oxide from being generated, and can be used as anti-inflammatory medicines for preventing and / or treating human and animals.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to diphenylheptane compounds in zedoary and its application. technical background [0002] Inflammation is a series of protective responses of the body to the damage caused by various inflammatory factors, and the vascular response is the central link of the inflammatory process. Inflammation usually causes a systemic reaction, which is usually characterized by fever, increased white blood cell count, and in severe cases, degeneration, necrosis, and dysfunction of the heart, liver, and kidneys to varying degrees. Acute inflammation mainly manifests as redness, swelling, heat, pain and dysfunction, which is a defense response of the body to stimulation. However, chronic inflammation is characterized by the persistence of inflammatory factors and damage to the body, which can lead to chronic cholecystitis, diabetes, chronic pyelonephritis, lung diseases, cancer, diseases of the card...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C39/21C07C39/15C07C37/70C07C69/21C07C67/48C07C49/248C07C49/255C07C45/78C07C43/23C07C41/34A61K31/05A61K31/222A61K31/12A61K31/085A61K31/09A61P29/00
Inventor 邱峰李军康宁陈丽霞
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com